Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

Retinal imaging think tank convened by the Alzheimer's Association to examine its promise in the early detection of Alzheimer's.

Snyder PJ, Snyder HM, Bain LJ.

Alzheimers Dement. 2020 Jan;16(1):244. doi: 10.1002/alz.12034. No abstract available.

PMID:
31914228
2.

Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward.

Alber J, Goldfarb D, Thompson LI, Arthur E, Hernandez K, Cheng D, DeBuc DC, Cordeiro F, Provetti-Cunha L, den Haan J, Van Stavern GP, Salloway SP, Sinoff S, Snyder PJ.

Alzheimers Dement. 2020 Jan;16(1):229-243. doi: 10.1002/alz.12006. Review.

PMID:
31914225
3.

Rates of age- and amyloid β-associated cortical atrophy in older adults with superior memory performance.

Dang C, Yassi N, Harrington KD, Xia Y, Lim YY, Ames D, Laws SM, Hickey M, Rainey-Smith S, Sohrabi HR, Doecke JD, Fripp J, Salvado O, Snyder PJ, Weinborn M, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL Research Group.

Alzheimers Dement (Amst). 2019 Aug 12;11:566-575. doi: 10.1016/j.dadm.2019.05.005. eCollection 2019 Dec.

4.

Biomarkers and Non-Calcified Coronary Artery Plaque Progression in Older Men Treated with Testosterone.

Shaikh K, Ellenberg SS, Nakanishi R, Snyder PJ, Lee J, Wenger NK, Lewis CE, Swerdloff RS, Preston P, Hamal S, Stephens-Sheilds A, Bhasin S, Cherukuri L, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Matsumoto AM, Molich ME, Alla VM, Birudaraju D, Nezarat N, Rai K, Almeida S, Roy SK, Sheikh M, Trad G, Budoff M.

J Clin Endocrinol Metab. 2019 Nov 30. pii: dgz242. doi: 10.1210/clinem/dgz242. [Epub ahead of print]

PMID:
31784747
5.

Blood-based biomarkers for Alzheimer's disease and related dementias: Keys to success and things to consider.

Zetterberg H, Apostolova LG, Snyder PJ.

Alzheimers Dement (Amst). 2019 Nov 14;11:784-786. doi: 10.1016/j.dadm.2019.10.001. eCollection 2019 Dec. No abstract available.

6.

A Potential Association Between Retinal Changes, Subjective Memory Impairment, and Anxiety in Older Adults at Risk for Alzheimer's Disease: A 27-Month Pilot Study.

Cheng DL, Thompson L, Snyder PJ.

Front Aging Neurosci. 2019 Oct 29;11:288. doi: 10.3389/fnagi.2019.00288. eCollection 2019.

7.

Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment.

Ramos DM, d'Ydewalle C, Gabbeta V, Dakka A, Klein SK, Norris DA, Matson J, Taylor SJ, Zaworski PG, Prior TW, Snyder PJ, Valdivia D, Hatem CL, Waters I, Gupte N, Swoboda KJ, Rigo F, Bennett CF, Naryshkin N, Paushkin S, Crawford TO, Sumner CJ.

J Clin Invest. 2019 Nov 1;129(11):4817-4831. doi: 10.1172/JCI124120.

8.

Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial.

Cunningham GR, Ellenberg SS, Bhasin S, Matsumoto AM, Parsons JK, Preston P, Cauley JA, Gill TM, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Pahor M, Crandall JP, Molitch ME, Cifelli D, Basaria S, Diem SJ, Stephens-Shields AJ, Hou X, Snyder PJ.

J Clin Endocrinol Metab. 2019 Dec 1;104(12):6238-6246. doi: 10.1210/jc.2019-00806.

PMID:
31504596
9.

Clinically Meaningful Change in Sexual Desire in the Psychosexual Daily Questionnaire in Older Men from the TTrials.

Stephens-Shields AJ, Wang C, Preston P, Snyder PJ, Swerdloff RS.

J Sex Med. 2019 Jul;16(7):951-953. doi: 10.1016/j.jsxm.2019.04.003. Epub 2019 May 14.

PMID:
31101538
10.

Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.

Bransby L, Lim YY, Ames D, Fowler C, Roberston J, Harrington K, Snyder PJ, Villemagne VL, Salvado O, Masters CL, Maruff P for the AIBL Research Group.

J Clin Exp Neuropsychol. 2019 Aug;41(6):591-600. doi: 10.1080/13803395.2019.1593949. Epub 2019 Mar 29.

PMID:
30924399
11.

Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype.

Ruhno C, McGovern VL, Avenarius MR, Snyder PJ, Prior TW, Nery FC, Muhtaseb A, Roggenbuck JS, Kissel JT, Sansone VA, Siranosian JJ, Johnstone AJ, Nwe PH, Zhang RZ, Swoboda KJ, Burghes AHM.

Hum Genet. 2019 Mar;138(3):241-256. doi: 10.1007/s00439-019-01983-0. Epub 2019 Feb 20.

PMID:
30788592
12.

Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research.

Hampel H, Mesulam MM, Cuello AC, Khachaturian AS, Vergallo A, Farlow MR, Snyder PJ, Giacobini E, Khachaturian ZS.

J Prev Alzheimers Dis. 2019;6(1):2-15. doi: 10.14283/jpad.2018.43.

PMID:
30569080
13.

Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials.

Bhasin S, Ellenberg SS, Storer TW, Basaria S, Pahor M, Stephens-Shields AJ, Cauley JA, Ensrud KE, Farrar JT, Cella D, Matsumoto AM, Cunningham GR, Swerdloff RS, Wang C, Lewis CE, Molitch ME, Barrett-Connor E, Crandall JP, Hou X, Preston P, Cifelli D, Snyder PJ, Gill TM.

Lancet Diabetes Endocrinol. 2018 Nov;6(11):879-890. doi: 10.1016/S2213-8587(18)30171-2.

14.

Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.

Baker JE, Lim YY, Jaeger J, Ames D, Lautenschlager NT, Robertson J, Pietrzak RH, Snyder PJ, Villemagne VL, Rowe CC, Masters CL, Maruff P.

J Alzheimers Dis. 2018;65(3):977-988. doi: 10.3233/JAD-180344.

PMID:
30103330
15.

Noninvasive Stimulation of Neurotypic Cells Using Persistent Photoconductivity of Gallium Nitride.

Snyder PJ, Reddy P, Kirste R, LaJeunesse DR, Collazo R, Ivanisevic A.

ACS Omega. 2018 Jan 31;3(1):615-621. doi: 10.1021/acsomega.7b01894. Epub 2018 Jan 19.

16.

Validity and Clinically Meaningful Changes in the Psychosexual Daily Questionnaire and Derogatis Interview for Sexual Function Assessment: Results From the Testosterone Trials.

Wang C, Stephens-Shields AJ, DeRogatis LR, Cunningham GR, Swerdloff RS, Preston P, Cella D, Snyder PJ, Gill TM, Bhasin S, Matsumoto AM, Rosen RC.

J Sex Med. 2018 Jul;15(7):997-1009. doi: 10.1016/j.jsxm.2018.05.008.

17.

Discontinuation and nonpublication of interventional clinical trials conducted in patients with mild cognitive impairment and Alzheimer's disease.

Yilmaz T, Jutten RJ, Santos CY, Hernandez KA, Snyder PJ.

Alzheimers Dement (N Y). 2018 Apr 25;4:161-164. doi: 10.1016/j.trci.2018.03.005. eCollection 2018.

18.

Bioelectronics communication: encoding yeast regulatory responses using nanostructured gallium nitride thin films.

Snyder PJ, LaJeunesse DR, Reddy P, Kirste R, Collazo R, Ivanisevic A.

Nanoscale. 2018 Jun 21;10(24):11506-11516. doi: 10.1039/c8nr03684e.

19.

The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.

Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Snyder PJ, Khachaturian ZS.

Brain. 2018 Jul 1;141(7):1917-1933. doi: 10.1093/brain/awy132. Review.

20.

Change in retinal structural anatomy during the preclinical stage of Alzheimer's disease.

Santos CY, Johnson LN, Sinoff SE, Festa EK, Heindel WC, Snyder PJ.

Alzheimers Dement (Amst). 2018 Feb 7;10:196-209. doi: 10.1016/j.dadm.2018.01.003. eCollection 2018.

21.

Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.

Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA.

J Clin Endocrinol Metab. 2018 May 1;103(5):1715-1744. doi: 10.1210/jc.2018-00229.

PMID:
29562364
22.

Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study.

Alber J, McGarry K, Noto RB, Snyder PJ.

Front Aging Neurosci. 2018 Mar 6;10:60. doi: 10.3389/fnagi.2018.00060. eCollection 2018.

23.

Lessons From the Testosterone Trials.

Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Resnick SM, Budoff M, Mohler ER 3rd, Wenger NK, Cohen HJ, Schrier S, Keaveny TM, Kopperdahl D, Lee D, Cifelli D, Ellenberg SS.

Endocr Rev. 2018 Jun 1;39(3):369-386. doi: 10.1210/er.2017-00234.

24.

The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials.

Mohler ER 3rd, Ellenberg SS, Lewis CE, Wenger NK, Budoff MJ, Lewis MR, Barrett-Connor E, Swerdloff RS, Stephens-Shields A, Bhasin S, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Gill TM, Matsumoto AM, Molitch ME, Pahor M, Preston PE, Hou X, Cifelli D, Snyder PJ.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):681-688. doi: 10.1210/jc.2017-02243. Erratum in: J Clin Endocrinol Metab. 2020 Jan 1;105(1):.

25.

WITHDRAWN: Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research.

Hampel H, Mesulam MM, Cuello AC, Khachaturian AS, Farlow MR, Snyder PJ, Giacobini E, Khachaturian ZS; Cholinergic System Working Group.

Alzheimers Dement. 2017 Oct 10. pii: S1552-5260(17)33719-6. doi: 10.1016/j.jalz.2017.08.016. [Epub ahead of print]

PMID:
29028480
26.

Redefining Unexplained Anemia in Elderly-Reply.

Cohen HJ, Roy CN, Snyder PJ.

JAMA Intern Med. 2017 Sep 1;177(9):1395. doi: 10.1001/jamainternmed.2017.2970. No abstract available.

PMID:
28873192
27.

Meta-Epidemiology of Testosterone's Risks and Benefits-Will We Ever Know the Answer?-Reply.

Snyder PJ, Ellenberg SS.

JAMA Intern Med. 2017 Sep 1;177(9):1392-1393. doi: 10.1001/jamainternmed.2017.2967. No abstract available.

PMID:
28873191
28.

Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness.

Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Martins RN, Rainey-Smith S, Robertson J, Rowe CC, Salvado O, Doré V, Villemagne VL, Snyder PJ, Masters CL, Maruff P.

Alzheimers Dement (Amst). 2017 Jun 9;8:156-164. doi: 10.1016/j.dadm.2017.05.006. eCollection 2017.

29.

Autonomic Cardiac Function in Preclinical Alzheimer's Disease.

Santos CY, Machan JT, Wu WC, Snyder PJ.

J Alzheimers Dis. 2017;59(3):1057-1065. doi: 10.3233/JAD-170217.

PMID:
28697563
30.

Changes in Coronary Artery Plaque With Testosterone Therapy-Reply.

Budoff MJ, Ellenberg SS, Snyder PJ.

JAMA. 2017 Jun 20;317(23):2451. doi: 10.1001/jama.2017.6024. No abstract available.

31.

Persistent Photoconductivity, Nanoscale Topography, and Chemical Functionalization Can Collectively Influence the Behavior of PC12 Cells on Wide Bandgap Semiconductor Surfaces.

Snyder PJ, Kirste R, Collazo R, Ivanisevic A.

Small. 2017 Jun;13(24). doi: 10.1002/smll.201700481. Epub 2017 May 2.

PMID:
28464526
32.

Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis.

Santos CY, Snyder PJ, Wu WC, Zhang M, Echeverria A, Alber J.

Alzheimers Dement (Amst). 2017 Feb 9;7:69-87. doi: 10.1016/j.dadm.2017.01.005. eCollection 2017. Review.

33.

Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment.

Resnick SM, Matsumoto AM, Stephens-Shields AJ, Ellenberg SS, Gill TM, Shumaker SA, Pleasants DD, Barrett-Connor E, Bhasin S, Cauley JA, Cella D, Crandall JP, Cunningham GR, Ensrud KE, Farrar JT, Lewis CE, Molitch ME, Pahor M, Swerdloff RS, Cifelli D, Anton S, Basaria S, Diem SJ, Wang C, Hou X, Snyder PJ.

JAMA. 2017 Feb 21;317(7):717-727. doi: 10.1001/jama.2016.21044.

34.

Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.

Budoff MJ, Ellenberg SS, Lewis CE, Mohler ER 3rd, Wenger NK, Bhasin S, Barrett-Connor E, Swerdloff RS, Stephens-Shields A, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Gill TM, Matsumoto AM, Molitch ME, Nakanishi R, Nezarat N, Matsumoto S, Hou X, Basaria S, Diem SJ, Wang C, Cifelli D, Snyder PJ.

JAMA. 2017 Feb 21;317(7):708-716. doi: 10.1001/jama.2016.21043.

35.

Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial.

Roy CN, Snyder PJ, Stephens-Shields AJ, Artz AS, Bhasin S, Cohen HJ, Farrar JT, Gill TM, Zeldow B, Cella D, Barrett-Connor E, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Lewis CE, Matsumoto AM, Molitch ME, Pahor M, Swerdloff RS, Cifelli D, Hou X, Resnick SM, Walston JD, Anton S, Basaria S, Diem SJ, Wang C, Schrier SL, Ellenberg SS.

JAMA Intern Med. 2017 Apr 1;177(4):480-490. doi: 10.1001/jamainternmed.2016.9540. Erratum in: JAMA Intern Med. 2019 Mar 1;179(3):457.

36.

Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial.

Snyder PJ, Kopperdahl DL, Stephens-Shields AJ, Ellenberg SS, Cauley JA, Ensrud KE, Lewis CE, Barrett-Connor E, Schwartz AV, Lee DC, Bhasin S, Cunningham GR, Gill TM, Matsumoto AM, Swerdloff RS, Basaria S, Diem SJ, Wang C, Hou X, Cifelli D, Dougar D, Zeldow B, Bauer DC, Keaveny TM.

JAMA Intern Med. 2017 Apr 1;177(4):471-479. doi: 10.1001/jamainternmed.2016.9539. Erratum in: JAMA Intern Med. 2017 Apr 1;177(4):600. Erratum in: JAMA Intern Med. 2019 Mar 1;179(3):457.

37.

Brain amyloid in preclinical Alzheimer's disease is associated with increased driving risk.

Ott BR, Jones RN, Noto RB, Yoo DC, Snyder PJ, Bernier JN, Carr DB, Roe CM.

Alzheimers Dement (Amst). 2016 Nov 29;6:136-142. doi: 10.1016/j.dadm.2016.10.008. eCollection 2017.

38.

Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis.

Baker JE, Lim YY, Pietrzak RH, Hassenstab J, Snyder PJ, Masters CL, Maruff P.

Alzheimers Dement (Amst). 2016 Oct 18;6:108-121. doi: 10.1016/j.dadm.2016.09.002. eCollection 2017. Review.

39.

Variable phenotypic expression and onset in MYH14 distal hereditary motor neuropathy phenotype in a large, multigenerational North American family.

Iyadurai S, Arnold WD, Kissel JT, Ruhno C, Mcgovern VL, Snyder PJ, Prior TW, Roggenbuck J, Burghes AH, Kolb SJ.

Muscle Nerve. 2017 Aug;56(2):341-345. doi: 10.1002/mus.25491. Epub 2017 Feb 20.

40.

Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.

O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, Posner H, Hall J, Johnson L, Fong YL, Luthman J, Jeromin A, Batrla-Utermann R, Villarreal A, Britton G, Snyder PJ, Henriksen K, Grammas P, Gupta V, Martins R, Hampel H; Biofluid Based Biomarker Professional Interest Area.

Alzheimers Dement. 2017 Jan;13(1):45-58. doi: 10.1016/j.jalz.2016.09.014. Epub 2016 Nov 18.

41.

Nonvascular retinal imaging markers of preclinical Alzheimer's disease.

Snyder PJ, Johnson LN, Lim YY, Santos CY, Alber J, Maruff P, Fernández B.

Alzheimers Dement (Amst). 2016 Oct 1;4:169-178. eCollection 2016.

42.

Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia.

Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Bourgeat P, Martins RN, Salvado O, Rowe CC, Masters CL, Maruff P; AIBL Research Group.

J Mol Neurosci. 2016 Nov;60(3):362-370. Epub 2016 Sep 1.

PMID:
27586003
43.

Trabecular bone characterization on the continuum of plates and rods using in vivo MR imaging and volumetric topological analysis.

Chen C, Jin D, Liu Y, Wehrli FW, Chang G, Snyder PJ, Regatte RR, Saha PK.

Phys Med Biol. 2016 Sep 21;61(18):N478-N496. Epub 2016 Aug 19.

44.

BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease.

Lim YY, Hassenstab J, Cruchaga C, Goate A, Fagan AM, Benzinger TL, Maruff P, Snyder PJ, Masters CL, Allegri R, Chhatwal J, Farlow MR, Graff-Radford NR, Laske C, Levin J, McDade E, Ringman JM, Rossor M, Salloway S, Schofield PR, Holtzman DM, Morris JC, Bateman RJ; Dominantly Inherited Alzheimer Network.

Brain. 2016 Oct;139(Pt 10):2766-2777. Epub 2016 Aug 12.

45.

Testosterone Treatment in Older Men.

Snyder PJ, Ellenberg SS, Farrar JT.

N Engl J Med. 2016 Jul 7;375(1):90. doi: 10.1056/NEJMc1603665. No abstract available.

PMID:
27406354
46.

DADM: The first 2 years of the Alzheimer Association's open access journal to support the research and development of novel biomarkers and diagnostic approaches.

Snyder PJ.

Alzheimers Dement. 2016 Jul;12(7):755-7. doi: 10.1016/j.jalz.2016.06.008. Epub 2016 Jun 29. No abstract available.

PMID:
27370207
47.

Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.

Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Bhasin S, Matsumoto AM, Parsons JK, Gill TM, Molitch ME, Farrar JT, Cella D, Barrett-Connor E, Cauley JA, Cifelli D, Crandall JP, Ensrud KE, Gallagher L, Zeldow B, Lewis CE, Pahor M, Swerdloff RS, Hou X, Anton S, Basaria S, Diem SJ, Tabatabaie V, Ellenberg SS, Snyder PJ.

J Clin Endocrinol Metab. 2016 Aug;101(8):3096-104. doi: 10.1210/jc.2016-1645. Epub 2016 Jun 29.

48.

Prevalence of clinically silent corticotroph macroadenomas.

Guttenberg KB, Mayson SE, Sawan C, Kharlip J, Lee JY, Martinez-Lage M, Loevner LA, Ewanichak J, Grady MS, Snyder PJ.

Clin Endocrinol (Oxf). 2016 Dec;85(6):874-880. doi: 10.1111/cen.13146. Epub 2016 Jul 27.

PMID:
27346850
49.

Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score.

Lim YY, Snyder PJ, Pietrzak RH, Ukiqi A, Villemagne VL, Ames D, Salvado O, Bourgeat P, Martins RN, Masters CL, Rowe CC, Maruff P.

Alzheimers Dement (Amst). 2015 Dec 12;2:19-26. doi: 10.1016/j.dadm.2015.11.003. eCollection 2016.

50.

Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.

Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Porter T, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Martins RN, Salvado O, Bourgeat P, Rowe CC, Masters CL, Maruff P.

Neurology. 2016 Apr 26;86(17):1635-42. doi: 10.1212/WNL.0000000000002604. Epub 2016 Mar 30.

PMID:
27029632

Supplemental Content

Loading ...
Support Center